Found 16 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| Article
PubMed
| 3.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 3.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 4
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 630 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PP from human Y4R expressed in CHO-K1 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 4
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 631 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PP from human Y4R expressed in CHO-K1 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 1
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 7.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y1R expressed in BHK-21 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 1
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 7.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y1R expressed in BHK-21 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 794 | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 ... |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Activation of human Y2R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 ... |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 1
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Activation of human Y1R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 ... |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Activation of human Y2R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 ... |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 4
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Activation of human Y4R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 ... |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 4
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Activation of human Y4R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 ... |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 790 | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 ... |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 1
(Homo sapiens (Human)) | BDBM50466549
(CHEMBL4282168)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O |r| Show InChI InChI=1S/C79H120N26O19/c1-39(2)31-54(98-70(117)56(33-43-18-22-46(107)23-19-43)100-71(118)57(35-45-37-89-38-93-45)101-66(113)50(15-10-28-90-77(83)84)94-64(111)48-13-8-9-14-49(48)80)69(116)102-58(36-61(82)110)72(119)99-55(32-40(3)4)73(120)104-62(41(5)6)74(121)105-63(42(7)106)75(122)97-52(17-12-30-92-79(87)88)65(112)96-53(26-27-60(81)109)68(115)95-51(16-11-29-91-78(85)86)67(114)103-59(76(123)124)34-44-20-24-47(108)25-21-44/h8-9,13-14,18-25,37-42,50-59,62-63,106-108H,10-12,15-17,26-36,80H2,1-7H3,(H2,81,109)(H2,82,110)(H,89,93)(H,94,111)(H,95,115)(H,96,112)(H,97,122)(H,98,117)(H,99,119)(H,100,118)(H,101,113)(H,102,116)(H,103,114)(H,104,120)(H,105,121)(H,123,124)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,62+,63+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Activation of human Y1R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 ... |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |